statistiche ricercatore

Continente	#
NA - Nord America	514
AS - Asia	377
EU - Europa	292
SA - Sud America	48
Continente sconosciuto - Info sul continente non disponibili	25
AF - Africa	20
OC - Oceania	2
Totale	1.278

Nazione	#
US - Stati Uniti d'America	503
CN - Cina	153
SG - Singapore	85
IE - Irlanda	69
HK - Hong Kong	49
DE - Germania	43
IT - Italia	39
VN - Vietnam	36
RU - Federazione Russa	35
BR - Brasile	34
FI - Finlandia	29
GB - Regno Unito	17
ZA - Sudafrica	15
SE - Svezia	14
FR - Francia	13
IN - India	11
NL - Olanda	8
CA - Canada	6
JP - Giappone	6
AT - Austria	5
BD - Bangladesh	5
EC - Ecuador	5
PK - Pakistan	5
TR - Turchia	5
AR - Argentina	4
IL - Israele	4
MX - Messico	4
PL - Polonia	4
BE - Belgio	3
IQ - Iraq	3
LT - Lituania	3
AU - Australia	2
NP - Nepal	2
SA - Arabia Saudita	2
UA - Ucraina	2
UZ - Uzbekistan	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AZ - Azerbaigian	1
BY - Bielorussia	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
EU - Europa	1
GR - Grecia	1
HU - Ungheria	1
ID - Indonesia	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
LV - Lettonia	1
LY - Libia	1
MA - Marocco	1
MU - Mauritius	1
MY - Malesia	1
PE - Perù	1
PH - Filippine	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	1.254

Nome	#
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation.	167
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia	142
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts	136
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome	124
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes	115
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.	107
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms	106
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations	102
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia	97
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications	95
Gene expression and risk of leukemic transformation in myelodysplasia	82
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial	5
Totale	1.278

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	41	0	0	0	2	2	2	1	0	1	1	10	22
2022/2023	186	23	16	4	8	8	12	0	8	87	2	13	5
2023/2024	111	16	22	2	8	6	33	0	3	0	3	4	14
2024/2025	212	11	13	7	5	4	22	12	14	48	9	29	38
2025/2026	553	43	40	41	68	78	25	109	30	52	37	16	14
2026/2027	4	3	1	0	0	0	0	0	0	0	0	0	0
Totale													1.278